MISSIONThe EF Clif is intended to support high quality research and education on Acute-on-Chronic Liver Failure (ACLF), in order to improve the quality of life and to increase the survival of patients with liver cirrhosis.
VISIONOur aim is helping investigators to achieve their objectives and being a referent in ACLF research, in order to increase survival of patients with liver cirrhosis and improve their quality of life.
The ILC took place from 10 to 14 April, 2019. in Vienna with the attendance of around 10,000 delegates from more than 121 countries. During the meeting, the EASL-CLIF Consortium celebrated its General Assembly and the 1st meeting of the renovated Steering Committee
The EF Clif organized an academic event at the central headquarters of the Foundation, followed by a dinner at the Grifols Museum, in order to celebrate the 10th anniversary of the first and largest research activity of the EF Clif, the EASL-Clif Consortium
The DECISION Project has as a main objective to enhance the understanding of the pathophysiology of decompensation of cirrhosis, by integrating results of multiomic profiles together with comprehensive clinical data and biological samples of more than 2,200 patients. The project will start in 2020 and will last for 6 years.
In the premises of the Fondazione Cini, the most active members of the Clif Consortium and other outstanding researchers from around the world attended a two-day Symposium entitled "The Acute-on-Chronic Liver Failure syndrome in cirrhosis". The attendants were invited to a formal dinner on Friday 18 and enjoyed an evening together, while sharing their impressions on the advances leaning to a best understanding of ACLF.
Dr Zaccherini is a Research Fellow in hepatology of the University of Bologna and carries out his clinical activity at the S. Orsola- Malpighi University Hospital. He will stay for six months in our headquarters in Barcelona, working on the characteristics of different organ failures in patients with acutely decompensated cirrhosis, using the metabolomics data from the CANONIC Study cohort.
The ILC took place from 10 to 14 April, 2019. in Vienna with the attendance of around 10,000 delegates from more than 121 countries. During the meeting, the EASL-CLIF Consortium celebrated its General Assembly and the 1st meeting of the renovated Steering Committee
The EF Clif organized an academic event at the central headquarters of the Foundation, followed by a dinner at the Grifols Museum, in order to celebrate the 10th anniversary of the first and largest research activity of the EF Clif, the EASL-Clif Consortium
In only 8 months, the participant centres in the ACLARA Study had reached 745 inclusions, from 38 centres in 5 different countries. There were five active centres in Argentina, 21 in Brazil, five in Chile, eight in Mexico and five in Peru. By the end of the year, the patients in the study were more than 1,000, including centres from Colombia and Paraguay, in addition to the previously mentioned ones.
The DECISION Project has as a main objective to enhance the understanding of the pathophysiology of decompensation of cirrhosis, by integrating results of multiomic profiles together with comprehensive clinical data and biological samples of more than 2,200 patients. The project will start in 2020 and will last for 6 years.
In the premises of the Fondazione Cini, the most active members of the Clif Consortium and other outstanding researchers from around the world attended a two-day Symposium entitled "The Acute-on-Chronic Liver Failure syndrome in cirrhosis". The attendants were invited to a formal dinner on Friday 18 and enjoyed an evening together, while sharing their impressions on the advances leaning to a best understanding of ACLF.
A group of ACLARA investigators met during the ASSLD in Boston to share their impressions to the study. Researchers from Latin America and Spain had the opportunity to discuss about the advances of the project and to plan the next steps of it.
Dr Zaccherini is a Research Fellow in hepatology of the University of Bologna and carries out his clinical activity at the S. Orsola- Malpighi University Hospital. He will stay for six months in our headquarters in Barcelona, working on the characteristics of different organ failures in patients with acutely decompensated cirrhosis, using the metabolomics data from the CANONIC Study cohort.
© 2020 EF Clif
